Predictors of early worsening after switch to aripiprazole: a randomized, controlled, open-label study.
about
Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations.Dopamine supersensitivity psychosis and dopamine partial agonist: a retrospective survey of failure of switching to aripiprazole in schizophreniaAntipsychotic polypharmacy in schizophrenia: benefits and risks.Switching antipsychotic medication to aripiprazole: position paper by a panel of Italian psychiatrists.Factors Related to Early Clinical Effects of Quetiapine Extended-Release: A Multinational, Prospective, Observational Study.Comparative effectiveness of switching antipsychotic drug treatment to aripiprazole or ziprasidone for improving metabolic profile and atherogenic dyslipidemia: a 12-month, prospective, open-label study.
P2860
Predictors of early worsening after switch to aripiprazole: a randomized, controlled, open-label study.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Predictors of early worsening ...... controlled, open-label study.
@en
Predictors of early worsening ...... controlled, open-label study.
@nl
type
label
Predictors of early worsening ...... controlled, open-label study.
@en
Predictors of early worsening ...... controlled, open-label study.
@nl
prefLabel
Predictors of early worsening ...... controlled, open-label study.
@en
Predictors of early worsening ...... controlled, open-label study.
@nl
P2093
P2860
P1476
Predictors of early worsening ...... controlled, open-label study.
@en
P2093
Alberto Chiesa
Ashwin A Patkar
Chi-Un Pae
Laura Mandelli
Sara Gibiino
P2860
P304
P356
10.2165/11533060-000000000-00000
P577
2010-01-01T00:00:00Z